Genoil Inc. (GNOLF)
OTCMKTS · Delayed Price · Currency is USD
0.0197
0.00 (0.00%)
Nov 12, 2026, 4:00 PM EST
Genoil Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 0 | 0 | 0.01 | 0.01 | 0.01 | 0 |
Cash & Short-Term Investments | 0 | 0 | 0.01 | 0.01 | 0.01 | 0 |
Cash Growth | -99.98% | -99.90% | 15.02% | 107.45% | 41933.33% | -99.65% |
Other Receivables | - | - | - | - | 0.1 | 0.12 |
Receivables | - | - | - | - | 0.1 | 0.12 |
Prepaid Expenses | 0 | 0.01 | 0.08 | 0.08 | 0 | 0.01 |
Total Current Assets | 0 | 0.01 | 0.1 | 0.1 | 0.11 | 0.12 |
Property, Plant & Equipment | - | - | - | 0.04 | 0.04 | 0.04 |
Other Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 |
Other Long-Term Assets | - | - | 0.04 | 0.1 | - | - |
Total Assets | 0 | 0.01 | 0.13 | 0.24 | 0.15 | 0.17 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 0.12 | 0.12 | 0.16 | 0.11 | 0.12 | 0.11 |
Accrued Expenses | 0.08 | 0.07 | 0.04 | 0.06 | 5.68 | 4.14 |
Short-Term Debt | 0.13 | 0.1 | 0.05 | - | - | - |
Current Portion of Long-Term Debt | - | - | - | - | 5.33 | 4.93 |
Total Current Liabilities | 0.33 | 0.29 | 0.24 | 0.17 | 11.12 | 9.19 |
Long-Term Debt | 0.22 | 0.22 | 0.21 | 0.21 | - | - |
Total Liabilities | 0.55 | 0.51 | 0.46 | 0.38 | 11.12 | 9.19 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 64.79 | 64.66 | 64.2 | 63.64 | 51.47 | 50.92 |
Additional Paid-In Capital | 43.1 | 41.61 | 41.62 | 40.28 | 37.3 | 36.15 |
Retained Earnings | -108.21 | -106.56 | -105.92 | -103.84 | -99.51 | -95.87 |
Comprehensive Income & Other | -0.23 | -0.22 | -0.22 | -0.22 | -0.22 | -0.22 |
Shareholders' Equity | -0.55 | -0.51 | -0.32 | -0.14 | -10.96 | -9.02 |
Total Liabilities & Equity | 0 | 0.01 | 0.13 | 0.24 | 0.15 | 0.17 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 0.35 | 0.32 | 0.26 | 0.21 | 5.33 | 4.93 |
Net Cash (Debt) | -0.35 | -0.32 | -0.25 | -0.2 | -5.32 | -4.93 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -0.00 | -0.00 | -0.00 | -0.00 | -0.01 | -0.01 |
Filing Date Shares Outstanding | 2,030 | 2,018 | 1,969 | 1,913 | 696.01 | 640.63 |
Total Common Shares Outstanding | 2,030 | 2,018 | 1,969 | 1,913 | 696.01 | 640.63 |
Working Capital | -0.33 | -0.29 | -0.15 | -0.07 | -11.01 | -9.06 |
Book Value Per Share | -0.00 | -0.00 | -0.00 | -0.00 | -0.02 | -0.01 |
Tangible Book Value | -0.55 | -0.51 | -0.32 | -0.14 | -10.96 | -9.02 |
Tangible Book Value Per Share | -0.00 | -0.00 | -0.00 | -0.00 | -0.02 | -0.01 |
Land | - | - | - | 0.04 | 0.04 | 0.04 |